this work not to alter the case fatality rate, suggest that each year about 170 cases and 16 deaths from ulcer complications are attributable to its use in New South Wales. This estimate is lower than for non-steroidal anti-inflammatory drugs because aspirin is regularly used less often by subjects in this age group in New South Wales (D A Henry et al, 3rd international conference on pharmacoepidemiology, Minneapolis, 1987) .
The suggestion that corticosteroids increase the case fatality rate from complications of peptic ulcer is a data derived hypothesis and should be interpreted with caution. Furthermore, the estimate of the relative risk is approximate because of small numbers. Nevertheless, the possibility ofa substantially increased case fatality rate for users of corticosteroids is supported by data from an extensive survey of gastrointestinal bleeding published by the American Society for Gastrointestinal Endoscopy.9 Interestingly, in our study the epidemiological data were backed by clinical evidence that the patients who died had suffered from adverse events which in some instances could be ascribed to the direct effect of corticosteroids, in particular overwhelming infections. Especially notable were two cases of staphylococcal septicaemia which were thought to be due to infection of intravenous cannula sites and thus by implication were preventable. On the basis of a meta-analysis of prospective randomised trials Messer et al concluded that corticosteroid treatment roughly doubled the incidence of haemorrhage from peptic ulcers.10 If our estimate of an increased fatality rate is correct then the risk of users of steroids developing and subsequently dying from ulcer complications might be about eight times higher than for non-users. Although this is a substantial increase for the individual, in population terms it is a small risk because of the low prevalence ofuse of steroids in the community.
Of the anti-inflammatory drugs, aspirin and non-steroidal antiinflammatory drugs, particularly the latter, are the important causes of morbidity and mortality in the community. Unlike steroids their intrinsic toxicity is not high. Rather, difficulties arise because of their extraordinarily wide use. Epidemiologically the relation is dominated by a high prevalence of the risk factor rather than a high relative risk of the disease. Thus the main thrust of attempts to reduce morbidity and mortality from non-steroidal anti-inflammatory drugs in the community should be to limit their use rather than to attempt to lower relative risk further by widespread coprescription of agents designed to "protect" the gastrointestinal mucosa, such as prostaglandins, sucralfate, or histamine H2 antagonists. While these measures may prove to have a role in a limited number of individuals, the greatest need is for more information on the factors which control prescribing decisions so that we can identify opportunities for intervention. Filtrates from cultures of P acnes isolated from cervical lymph node biopsy specimens and blood samples from patients with Kawasaki disease were studied and compared with samples from control subjects. After inoculation of human embryo liver ceils with filtrates from the patients a cytopathogenic effect and vacuolation were seen. A specific cytopathogenic substance was found in only the filtrates ofcultures from patients with Kawasaki disease; it was a protein of about isoelectric point 7*0 with a molecular weight of about 100 000 daltons. The amount of IgG antibody to this cytopathogenic protein was measured by enzyme linked immunosorbent assay (ELISA) in serum samples taken from 63 patients in the acute phase of Kawasaki disease (mean 5-2 (SD 1X1) days after onset of illness), 45 in the subacute phase (mean 23X6 (3-3) days), and 51 in the convalescent phase (mean 18-5 (4-1) months) and from 102 control subjects matched for age. Titres of IgG antibody were significantly raised in patients with Kawasaki disease, particularly in the acute and subacute phases of the illness, compared with in the control subjects.Introduction Kawasaki disease was first described in 1967,1 and the number of patients affected is increasing not only in Japan but also in the United States, Europe, and Korea.2-5 Epidemiological studies have suggested either an infectious aetiology or an immune response to an infectious agent(s),6 but the exact cause of the disease has not been determined.
In 1983 we isolated Propionibacterium acnes from a lymph node biopsy specimen from a 6 year old boy with typical symptoms of Kawasaki disease on the 1 th day of a second recurrence of the disease.78 P acnes may be implicated in the pathogenesis of this disease for the following reasons: (1) the incidence of isolation of P acnes from samples of cervical lymph nodes and blood from patients with Kawasaki disease compared with a control group has been high7 8; (2) intraperitoneal inoculation of guinea pigs with this micro-organism resulted in depilation, lymphadenopathy, hepatosplenomegaly, and coronary arteritis7 8; (3) guinea pigs sensitised to BCG had an increased footpad reaction to BCG after a subsequent intraperitoneal injection of P acne?; (4) filtrates of cultures of P acnes induced a cytopathogenic effect and vacuolation when inoculated into human embryo liver cells and these effects were less commonly seen with filtrates of cultures of the standard strain or other strains isolated from blood samples of patients with other illnesses7 8; and (5) when the filtrate from cultures of P acnes was heated at 1000C for 30 minutes or treated with serum from convalescent patients neither vacuolation nor cytopathogenic effects occurred in fetal liver cells.78
These results suggested that the strain isolated from patients with Kawasaki disease may produce a cytopathogenic substance. In this study we isolated this substance and measured the amount of IgG antibody against it in the serum of patients with Kawasaki disease and a group of control subjects.
Materials, subjects, and methods
MICRO-ORGANISMS
We used the method of Kato et alto isolate and type P acnes.7 After initial isolation the strains of P acnes were preserved in cooked meat broth at room temperature. We analysed filtrates from cultures of micro-organisms isolated from four patients with typical symptoms of Kawasaki disease, one patient with leukaemia, and one patient with congenital heart disease, as well as those from housedust mites collected from the houses of patients with Kawasaki disease and micro-organisms of the standard strain (ATCC 11827). Filtrates from the medium alone served as a control.
ANALYSIS OF FILTRATES FROM CULTURES
Micro-organisms were grown for four to 10 days at 370C in Gifu anaerobic medium broth (peptone 10 g/l, soy peptone 3 g/l, protease peptone W 10 g/l, peptide digest serum powder13-5 g/l, meat extract 2-2 g/l, yeast extract 5 g/l, liver extract 1 2 g/l, glucose 3 g/l, potassium dihydrogen phosphate 2-5 g/l, sodium chloride 3 g/l, soluble starch 5 g/l, cysteine hydrochloride 0 3 g/l, and sodium thioglycollate 0 3 g/l in distilled water; pH 7 3 (SD 0 1)). The supernatant was centrifuged and filtered through a 0-22 [tm Millipore filter; the filtrate was dialysed after being salted out with 80% ammonium sulphate. The concentrated filtrate was fractionated by gel filtration and further fractionated by flat bed isoelectrofocusing. The fractionate (containing 15fig protein) was inoculated into human embryo liver cells to see the cytopathogenic effect and vacuolation. Vacuolations induced in these liver cells were analysed by polyacrylamide and sodium dodecylsulphate-polyacrylamide gel electrofocusing.
-Gel filtration was performed using LKB Ultrogel AcA44, and the filtrate was extracted with phosphate buffered saline, pH 7-2. An LKB Multiphor was used for flat bed isoelectrofocusing. Fractionation was carried out with the Ultrodex system and Ampholine, pH 3 5-10. LKB Multiphor and Ampholine plates, pH 3-5-9-5, were used for polyacrylamide gel electrofocusing, and the gel was stained with Coomassie brilliant blue after focusing. Sodium dodecylsulphate-polyacrylamide gel electrofocusing was performed using microslab electrophoresis through a 12 5% acrylamide gel, which was stained with silver after staining with Coomassie brilliant blue.
MEASUREMENT OF THE IgG ANTIBODIES TO CYTOPATHOGENIC SUBSTANCE IgG antibodies against the cytopathogenic substance extracted from filtrates of cultures of P acnes isolated from the patients with Kawasaki disease were measured in serum samples by an indirect enzyme linked immunosorbent assay (ELISA). Polystyrene flat bottomed microtitration plates (Flow Laboratories Inc) were coated with 100 P1 of the cytopathogenic substance and a solution containing protein 50 mg/l in a 0-05M carbonate-bicarbonate buffer (pH 9-6). After incubation at 40C overnight the plates were washed four times with 0-05% Tween 20 in phosphate buffered saline; 100 V1 of test serum diluted 1 in 4 with 0-05% Column was Ultragel AcA44; bed dimensions 2 5x58 cm; eluent phosphate buffered saline, pH 7-2; sample volume 4 ml; and flow rate 30 mI/min. The small peak (arrow) at 100000 daltons molecular weight was seen only in filtrates of cultures from patients with Kawasaki disease.
Then 100 p1 of 0-04% o-phenylenediamine in citrate-phosphate buffer (pH 5-0) was added, and the plates were incubated in the dark at room temperature for 30 minutes. The reaction was stopped by adding 50 W1 2-5M sulphuric acid, and the absorption of the plates was measured at 486 nm by an ETY-96 ELISA Analyzer (TOYO, Oriental Instruments Ltd).
Serum samples were collected from 63 patients two to eight days (mean 5-2 (SD1I 1) days) after the onset of Kawasaki disease (acute phase), from 45 patients 14-33 days (23-6 (3-3) days) after the onset of disease (subacute phase), and from 51 patients 11-22 months (18-5 (4-1) months) after the onset of disease (convalescent phase). All patients were less than 4 years old (mean 2-0 (1-6) years). Samples were also taken from 102 subjects (mean age 1-8 (1-2) years), who served as controls for the ELISA procedure. There was no difference in age between the patients and the controls (p>05). The prevalence of antibodies to the cytopathogenic substance in normal children and adults was determined in serum samples from 168 subjects from the general population aged 0-35 years (mean 6-0 (7-6) years). Finally, serum samples were collected from three patients with recurrent Kawasaki disease during the first eight days of the initial attack and the recurrence to measure serial antibody titres. Figure 1 shows the results of gel filtration at an optical density of 280 nm. Peaks around 200 000 and 20 000-30 000 daltons molecular weight were seen in the filtrates from cultures ofall strains and the control medium, which did not induce cytoplasmic vacuolations in embryo liver cells. In the filtrates from cultures of strains from patients with Kawasaki disease, however, a small peak of about 100000 daltons molecular weight was seen, which caused vacuolation in embryo liver cells.
Results

ANALYSIS OF FILTRATES FROM CULTURES
Flat bed isoelectrofocusing (fig 2) showed a specific fractionation band with an isoelectric point about 7 0 in filtrates of cultures from all four of the patients with Kawasaki disease; this induced vacuolation in embryo liver cells (fig 3) . There were no such bands in the fractions extracted from the four control strains (fig 2) .
These results agreed with those obtained with analysis of polyacrylamide gel electrofocusing. Furthermore, these fractionations were evaluated with sodium dodecylsulphate-polyacrylamide gel electrofocusing, which showed the molecular weight to be about 100 000 daltons. We tentatively named it cytopathogenic protein. Group A are controls: 1 is pure Gifu anaerobic medium (GAM) broth, 2 is filtrate from culture ofP acnes isolated from housedust mite, 3 is filtrate from culture of P acnes isolated from a patient with leukaemia, and 4 is filtrate from culture of standard strain (ATCC 11827). Group B (5) (6) (7) (8) variance the differences were significant (Fo,3,257)=7-7169, p<0001). Thus we made multiple comparisons of the values in these groups individually by Student's t test. The values were raised both in the group that had been ill for two to eight days and in the group that had been ill for 14-33 days and were significantly different from those in the controls (p<0005 and p<0 0001 respectively). The mean value in the patients in the convalescent phase was similar to that in the controls.
. . Figure 4 shows the prevalence of IgG antibodies against cytopathogenic protein in the general population. The values for children younger than 4 years old were not raised, but they increased with age thereafter. Figure 5 shows that in all three patients with recurrent Kawasaki disease studied the antibody titres were raised in the acute and subacute phases but fell in the convalescent phase ofthe first attack. In two patients, however, the titres rose again when the illness recurred, to values higher than those during the first attack. 
Discussion
P acnes is not usually pathogenic in children, but previous studies have suggested that when isolated from patients with Kawasaki disease it may have some pathogenicity.7-' Experiments with P acnes isolated from patients with the disease suggested that it was producing a cytopathogenic substance. Our results suggest that this substance, which we called cytopathogenic protein, may be a cytopathogenic or toxigenic protein, or an exotoxin. Serum titres of IgG antibodies to cytopathogenic protein measured by ELISA were significantly raised in the serum samples from patients with Kawasaki disease, which suggests that cytopathogenic protein may have some aetiological role in the disease. This agrees with previous studies assessing the agglutination test and cytoplasmic vacuolation in embryonic liver cells.7 9 Epidemiological studies have reported several outbreaks of Kawasaki disease in Japan, which have occurred at regular intervals of three years, which suggests an infectious cause. It is, however, difficult to explain how Kawasaki disease can be epidemic if caused by P acnes alone because P acnes is the principal indigenous bacterium of human skin. We found that most infants and young children in the general population had no antibodies to the cytopathogenic protein and that the antibody titres gradually increased with age. This may explain why it is mainly infants and younger children who suffer from Kawasaki disease. The three year interval between epidemics noted repeatedly in Japan and the United States indicates that after a large outbreak the disease cannot recur until the susceptible group of children has increased adequately. It correlates exactly with the age group at greatest risk.
When serial antibody titres were measured in patients with Kawasaki disease two patterns were noted: in one group of patients a high antibody titre was maintained for a long time, but in another the titre fell during the early convalescent phase.'0 The patients with maintained high titres of antibodies to cytopathogenic protein may have been repeatedly infected with this indigenous bacterium or releasing this protein and therefore receiving numerous "booster" effects. Epidemiological studies showed that 2% or 3% of the patients had recurrences of Kawasaki disease,26 which could occur in the group of patients in whom the antibody titres fell during the convalescent phase. We measured serial antibody titres in three patients from the time of illness to its recurrence. For two of them the titres fell in the convalescent phase after the first illness and increased again when the illness recurred, which agrees with our hypothesis.
Why and how P acnes changes to produce a substance similar to an exotoxin or develops its pathogenic effects is not known. Pathogenicity may be caused by a bacteriophage or plasmid or other unknown factors, although Yamamoto et al reported that no plasmid was present in the bacterial cells." The isolation of the strain of P acnes producing the cytopathogenic protein in patients with Kawasaki disease and their significantly higher antibody titres against this protein, however, suggest a causal role for this bacterium in Kawasaki disease.
